Fenofibrate Facilitates Post-Active Tuberculosis Infection in Macrophages and is Associated with Higher Mortality in Patients under Long-Term Treatment.

Liu, Ching-Lung; Lu, Yen-Ta; Tsai, I-Fan; Wu, Ling-Chiao; Chien, Wu-Chien; Chung, Chi-Hsiang; Ma, Kuo-Hsing

Liu, Ching-Lung; Lu, Yen-Ta; Tsai, I-Fan; Wu, Ling-Chiao; Chien, Wu-Chien; Chung, Chi-Hsiang; Ma, Kuo-Hsing.

Afiliación

Liu CL; Division of Chest Medicine, Department of Internal Medicine, MacKay Memorial Hospital, Taipei 104, Taiwan.
Lu YT; Department of Medicine, MacKay Medical College, New Taipei City 252, Taiwan.
Tsai IF; Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei 114, Taiwan.
Wu LC; Division of Chest Medicine, Department of Internal Medicine, MacKay Memorial Hospital, Taipei 104, Taiwan.
Chien WC; Department of Medicine, MacKay Medical College, New Taipei City 252, Taiwan.
Chung CH; Department of Medical Research, MacKay Memorial Hospital, Taipei 104, Taiwan.
Ma KH; Department of Medical Research, MacKay Memorial Hospital, Taipei 104, Taiwan.

J Clin Med ; 9(2)2020 Jan 25.

Article en En | MEDLINE | ID: mdl-31991736

Palabras clave

fenofibrate; lipid; mycobacterial tuberculosis; tuberculosis infection

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: J Clin Med Año: 2020 Tipo del documento: Article País de afiliación: Taiwán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google